Phibro Animal Health Co. (NASDAQ:PAHC) Short Interest Down 17.5% in March

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 706,200 shares, a decrease of 17.5% from the March 15th total of 855,800 shares. Approximately 3.5% of the company's shares are short sold. Based on an average trading volume of 145,000 shares, the days-to-cover ratio is presently 4.9 days.

Phibro Animal Health Stock Up 0.2 %

Shares of PAHC stock traded up $0.02 on Friday, reaching $13.11. 120,894 shares of the company were exchanged, compared to its average volume of 123,003. The company has a market cap of $530.96 million, a price-to-earnings ratio of 36.42, a PEG ratio of 4.84 and a beta of 0.75. The company has a 50-day moving average of $12.54 and a 200-day moving average of $11.75. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.12 and a quick ratio of 1.60. Phibro Animal Health has a one year low of $9.40 and a one year high of $15.98.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The business had revenue of $249.90 million for the quarter, compared to analysts' expectations of $242.91 million. Analysts anticipate that Phibro Animal Health will post 1.12 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 6th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 annualized dividend and a yield of 3.66%. Phibro Animal Health's payout ratio is 133.33%.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently added to or reduced their stakes in PAHC. China Universal Asset Management Co. Ltd. increased its stake in Phibro Animal Health by 358.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company's stock valued at $27,000 after buying an additional 1,843 shares during the last quarter. Rockefeller Capital Management L.P. increased its stake in Phibro Animal Health by 24,840.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,494 shares of the company's stock valued at $32,000 after buying an additional 2,484 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Phibro Animal Health by 92.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 2,478 shares of the company's stock valued at $33,000 after buying an additional 1,188 shares during the last quarter. FMR LLC increased its stake in Phibro Animal Health by 207.8% in the 1st quarter. FMR LLC now owns 2,158 shares of the company's stock valued at $33,000 after buying an additional 1,457 shares during the last quarter. Finally, Qube Research & Technologies Ltd purchased a new stake in Phibro Animal Health in the 3rd quarter valued at about $34,000. Institutional investors own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Tuesday.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.